» Authors » Takeshi Maehana

Takeshi Maehana

Explore the profile of Takeshi Maehana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 54
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shindo T, Ueki Y, Muranaka I, Kobayashi G, Miyamoto S, Kunishima Y, et al.
Int J Urol . 2025 Feb; PMID: 39945120
Objectives: To evaluate the preoperative risk factors for early intravesical recurrence after radical nephroureterectomy (RNU) in patients with upper urinary tract carcinoma (UTUC) according to the history of non-muscle invasive...
2.
Hiyama Y, Shindo T, Takahashi A, Fukuta F, Maehana T, Tachikawa K, et al.
J Infect Chemother . 2025 Jan; 31(4):102624. PMID: 39824249
Introduction: Febrile urinary tract infections are major complications of radical cystectomy; however, their characteristics after robot-assisted radical cystectomy remain unclear. Thus, we investigated the rate, severity, pathogens, and risk factors...
3.
Sato S, Tanaka T, Maehana T, Hashimoto K, Kobayashi K, Masumori N
Curr Urol . 2024 Aug; 18(2):139-143. PMID: 39176302
Background: We retrospectively evaluated the postoperative renal function in patients who had undergone radical prostatectomy to compare the incidences of postoperative acute kidney injury (AKI) among the patients who had...
4.
Kyoda Y, Hashimoto K, Takahashi A, Maehana T, Tachikawa K, Muranaka T, et al.
Curr Urol . 2024 Aug; 18(2):122-127. PMID: 39176291
Background: We clarified the predictive factors for changes in the status of medications for lower urinary tract symptoms (LUTS) 2 years after local radiotherapy for nonmetastatic prostate cancer. Materials And...
5.
Kyoda Y, Shibamori K, Shindo T, Maehana T, Hashimoto K, Kobayashi K, et al.
Int J Urol . 2024 Mar; 31(7):705-717. PMID: 38462732
Prostatic hyperplasia is very common in elderly men and is a typical disease that reduces quality of life. Histologically, hyperplasia of the prostate gland causes obstruction at the bladder outlet,...
6.
Saito Y, Shindo T, Kobayashi K, Hashimoto K, Kyoda Y, Maehana T, et al.
Hinyokika Kiyo . 2024 Feb; 70(1):1-5. PMID: 38321742
We experienced two cases of renal primary synovial sarcoma. Case 1: A 29-year-old man underwent laparoscopic radical nephrectomy and was originally diagnosed with renal cell carcinoma. Case 2: A 25-year-old...
7.
Tanaka T, Yamasaki K, Nofuji S, Maehana T, Shindo T, Kyoda Y, et al.
Int J Urol . 2024 Jan; 31(5):512-518. PMID: 38238898
Objectives: Our previous study suggested that the operative procedure is critical for the development of parastomal hernia. We developed a novel procedure for the creation of an ileal conduit stoma...
8.
Kyoda Y, Ichihara K, Muranaka I, Sakai Y, Nakamura M, Shinkai N, et al.
Low Urin Tract Symptoms . 2023 Aug; 15(6):225-230. PMID: 37614063
Objectives: We previously demonstrated the efficacy of cognitive behavioral therapy (CBT) using a self-check sheet for patients with nocturia in a randomized controlled study. Additionally, we investigated the efficacy of...
9.
Yamashita T, Sato T, Yamamoto K, Abiko A, Nishizawa K, Matsuda M, et al.
Front Med (Lausanne) . 2022 Oct; 9:926652. PMID: 36213646
For morbidly obese patients with end-stage kidney disease (ESKD), there are often difficulties in accessing, implementing, and maintaining kidney replacement therapy (KRT). Although recent weight-loss surgery has the potential to...
10.
Shindo T, Maehana T, Tanaka T, Hashimoto K, Kobayashi K, Takahashi A, et al.
Int J Urol . 2022 Jun; 29(9):1010-1016. PMID: 35654444
Objectives: To evaluate factors to predict overall survival of metastatic urothelial carcinoma patients treated with gemcitabine plus cisplatin chemotherapy or pembrolizumab therapy. Methods: We retrospectively evaluated two metastatic urothelial carcinoma...